Shandong Weigao Group Medical Polymer Co ( (HK:1066) ) just unveiled an announcement.
Shandong Weigao Group Medical Polymer Company Limited has announced its upcoming annual general meeting (AGM) scheduled for May 27, 2025. The AGM will address various resolutions, including the approval of the company’s audited financial statements for 2024, the declaration of a final dividend, re-appointment of auditors, and re-election of directors and supervisors. Additionally, a special resolution will consider granting the board a general mandate to issue and deal with shares. These resolutions are crucial for the company’s governance and strategic planning, potentially impacting its market positioning and shareholder value.
More about Shandong Weigao Group Medical Polymer Co
Shandong Weigao Group Medical Polymer Company Limited is a joint stock limited company incorporated in the People’s Republic of China. It operates in the medical polymer industry, focusing on the production and distribution of medical devices and related products.
YTD Price Performance: 29.64%
Average Trading Volume: 400
Technical Sentiment Signal: Hold
Current Market Cap: $3.28B
Find detailed analytics on 1066 stock on TipRanks’ Stock Analysis page.